about
Urotensin II in chronic liver disease: in vivo effect on vascular tone.Increased circulating urotensin II in cirrhosis: potential implications in liver disease.Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria.Increased risk of colorectal neoplasia in adult patients with cystic fibrosis: a matched case-control study.The prevalence of significant liver fibrosis and cirrhosis in haemophilia patients infected with hepatitis C using FibroScan.Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial.Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography.A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.Minimally invasive prediction of esophageal varices and portal hypertension.Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.Variant treatment for gastric varices with polidocanol foam using balloon-occluded retrograde transvenous obliteration: a pilot study.Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats.Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrelRadiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian studyUtility of transient elastography in the non-invasive evaluation of cystic fibrosis liver diseaseHepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentationUrotensin II: a vascular mediator in health and diseaseTransient elastography: the bigger we are, the harder to scanFeasibility and performance of the FibroScan XL probeImproved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009High-dose vitamin D supplementation and liver histology in NASHRisk stratification of upper GI bleeding with an esophageal capsule
P50
Q33378279-4D41E6CB-D57E-4DBE-8C5E-64EA309EB881Q36959222-535AD2D5-427B-4266-ACB0-9C25F52CB743Q38078075-6E856CD5-437F-4CD8-B5CF-98792E94E6FDQ38297230-FF54B952-28E8-4571-9863-DB5B9C64FE0AQ43596251-5C89A6BB-4CF2-4C8B-A3CF-4592A989811FQ43786026-52116432-6B6D-49EC-B311-A34C7E4E66EFQ45403827-3A8629E0-9551-4F7A-A15A-9D159BD18838Q45864533-6BB53AEE-5458-487E-8B99-3E7B2ECD1A59Q46450248-29EDABD5-7743-4725-AD69-3FB3BA4B67BAQ51376998-58D3DE19-9423-49F7-AD83-A477E5FB05D0Q51377773-EEBA52E6-E190-4790-AD0B-BE798010F431Q53060194-E43BF619-91D8-4239-BDA2-DD128E429967Q53077427-DEC3300C-B2BE-4058-B5FA-2A0F9E9784E2Q53130027-3BA7AA98-5A5A-4E8D-AC03-7ABB82864E9AQ54704146-36B763D0-5F6D-4640-B1E7-1ECCE405B5FDQ58007616-717ABC57-468E-4381-8544-FDBF1EF687B8Q61654204-270F3028-2465-487F-A712-630993F8CADDQ61790624-557352C3-1799-4F61-8BDA-16D124D936F3Q79763478-E41AEFBF-1998-46E4-88AA-51C46B0741BCQ81688385-E4F22C70-D4D0-4928-AB3F-0815E2958737Q82483886-286E7638-53DB-4AA9-B960-706C09EFED89Q82912728-52313A01-C6F6-4380-81A7-EB400BD3A72DQ83528232-11972046-F6A5-47A5-A5B7-CB87BC94F9C9Q85942699-55712820-D96D-45C5-9393-C16C92F7A998Q86245933-7E02A39C-7823-4ACE-9ECE-C66E40399008
P50
description
researcher ORCID ID = 0000-0002-0787-7273
@en
wetenschapper
@nl
name
William Kemp
@ast
William Kemp
@en
William Kemp
@es
William Kemp
@nl
type
label
William Kemp
@ast
William Kemp
@en
William Kemp
@es
William Kemp
@nl
prefLabel
William Kemp
@ast
William Kemp
@en
William Kemp
@es
William Kemp
@nl
P106
P1153
7101839549
P31
P496
0000-0002-0787-7273